Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future

Simone S. Schueller; Boris W. Kramer; Eduardo Villamor; Andreas Spittler; Angelika Berger; Ofer Levy

doi:10.3389/fped.2018.00199

Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future

Simone S. Schueller, Boris W. Kramer, Eduardo Villamor, Andreas Spittler, Angelika Berger, Ofer Levy

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Article number	199
Number of pages	17
Journal	Frontiers in pediatrics
Volume	6
DOIs	https://doi.org/10.3389/fped.2018.00199
Publication status	Published - 19 Jul 2018

Keywords

neonatal sepsis
preterm infant
adjuvant sepsis therapy
immunomodulation
pentoxifylline
lactoferrin
probiotics
human milk
LATE-ONSET SEPSIS
MESENCHYMAL STEM-CELLS
RANDOMIZED-CONTROLLED-TRIAL
PLACEBO-CONTROLLED-TRIAL
BIRTH-WEIGHT INFANTS
BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN
MONOCLONAL-ANTIBODY PAGIBAXIMAB
INTRAVENOUS IMMUNE GLOBULIN
ORAL ZINC SUPPLEMENTATION
EXTREMELY PRETERM INFANTS

Access to Document

10.3389/fped.2018.00199

Cite this

Schueller, S. S., Kramer, B. W., Villamor, E., Spittler, A., Berger, A., & Levy, O. (2018). Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future. Frontiers in pediatrics, 6, [199]. https://doi.org/10.3389/fped.2018.00199

@article{087a2a0fe34c41d490fc7dc398e3f22e,

title = "Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future",

keywords = "neonatal sepsis, preterm infant, adjuvant sepsis therapy, immunomodulation, pentoxifylline, lactoferrin, probiotics, human milk, LATE-ONSET SEPSIS, MESENCHYMAL STEM-CELLS, RANDOMIZED-CONTROLLED-TRIAL, PLACEBO-CONTROLLED-TRIAL, BIRTH-WEIGHT INFANTS, BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN, MONOCLONAL-ANTIBODY PAGIBAXIMAB, INTRAVENOUS IMMUNE GLOBULIN, ORAL ZINC SUPPLEMENTATION, EXTREMELY PRETERM INFANTS",

author = "Schueller, {Simone S.} and Kramer, {Boris W.} and Eduardo Villamor and Andreas Spittler and Angelika Berger and Ofer Levy",

year = "2018",

month = jul,

day = "19",

doi = "10.3389/fped.2018.00199",

language = "English",

volume = "6",

journal = "Frontiers in pediatrics",

issn = "2296-2360",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Immunomodulation to Prevent or Treat Neonatal Sepsis

T2 - Past, Present, and Future

AU - Schueller, Simone S.

AU - Kramer, Boris W.

AU - Villamor, Eduardo

AU - Spittler, Andreas

AU - Berger, Angelika

AU - Levy, Ofer

PY - 2018/7/19

Y1 - 2018/7/19

KW - neonatal sepsis

KW - preterm infant

KW - adjuvant sepsis therapy

KW - immunomodulation

KW - pentoxifylline

KW - lactoferrin

KW - probiotics

KW - human milk

KW - LATE-ONSET SEPSIS

KW - MESENCHYMAL STEM-CELLS

KW - RANDOMIZED-CONTROLLED-TRIAL

KW - PLACEBO-CONTROLLED-TRIAL

KW - BIRTH-WEIGHT INFANTS

KW - BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN

KW - MONOCLONAL-ANTIBODY PAGIBAXIMAB

KW - INTRAVENOUS IMMUNE GLOBULIN

KW - ORAL ZINC SUPPLEMENTATION

KW - EXTREMELY PRETERM INFANTS

U2 - 10.3389/fped.2018.00199

DO - 10.3389/fped.2018.00199

M3 - Review article

VL - 6

JO - Frontiers in pediatrics

JF - Frontiers in pediatrics

SN - 2296-2360

M1 - 199

ER -